Mesoblast Limited (MEOBF)
OTCMKTS · Delayed Price · Currency is USD
1.590
-0.310 (-16.32%)
At close: Jan 14, 2026

Mesoblast Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
2,3611,386754615273961
Market Cap Growth
-2.54%83.84%22.64%125.02%-71.58%-26.21%
Enterprise Value
2,3251,479797680299905
Last Close Price
1.590.960.660.830.481.52
PS Ratio
137.3080.58127.7281.9426.75129.28
PB Ratio
3.952.321.571.230.551.65
P/TBV Ratio
92.1854.10---1129.32
EV/Sales Ratio
124.5286.01135.0990.6529.26121.80
Debt / Equity Ratio
0.220.220.250.230.220.18
Asset Turnover
0.020.020.010.010.020.01
Quick Ratio
1.721.721.141.851.251.50
Current Ratio
1.991.991.181.951.361.57
Return on Equity (ROE)
-18.95%-18.95%-17.91%-16.40%-16.94%-17.48%
Return on Assets (ROA)
-5.37%-5.37%-5.41%-6.50%-7.16%-9.22%
Return on Capital Employed (ROCE)
-9.20%-9.20%-9.70%-11.00%-13.20%-16.80%
Earnings Yield
-4.33%-7.37%-11.67%-13.32%-33.44%-10.28%
FCF Yield
-2.14%-3.65%-6.46%-10.34%-24.14%-10.66%
Buyback Yield / Dilution
-22.41%-22.41%-26.87%-13.89%-12.86%-14.42%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.